<DOC>
	<DOCNO>NCT00942448</DOCNO>
	<brief_summary>The present study propose evaluate efficacy safety single dos Diclofenac HPBCD subcutaneous ( s.c. ) ( 25 mg/1 ml 50 mg/1 ml ) treatment acute moderate-to-severe pain dental impaction surgery .</brief_summary>
	<brief_title>Evaluation Efficacy Safety Diclofenac HPBCD 25 , 50 mg/ml Treatment Post-surgical Pain Following Dental Surgery</brief_title>
	<detailed_description />
	<mesh_term>Toothache</mesh_term>
	<mesh_term>Diclofenac</mesh_term>
	<criteria>Patients undergo surgical extraction single fully partially impacted mandibular 3rd molar require bone removal . Patients experience moderate severe postoperative pain within 6 hour end surgery . Preoperative laboratory test reference range without clinically significant abnormality judge Investigator . Surgery perform general anaesthesia , sedation . Complications occur surgical procedure period randomisation judge investigator . Acute local systemic infection time surgery could confound postsurgical evaluation . Patients clinical sign gastritis , gastroduodenal ulcer , GI bleeding . Other GI disturbance disease opinion investigator could negatively affected administration NSAIDs . Clinical sign history coagulation disorder could negatively affected NSAIDs administration . Hepatic renal impairment . Patients significant cardiac impairment , history cerebrovascular disease , history peripheral arterial disease , uncontrolled hypertension . Hypersensitivity diclofenac NSAIDs one study medication component . Patients chronic treatment topical systemic analgesics/NSAIDs . Patients treatment medication may affect treatment efficacy evaluation . Patients treatment medication whose concomitant use may susceptible interaction diclofenac may affect safety .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2011</verification_date>
</DOC>